Keywords: losses, deepen, biomarin, pharmaceutical, usa, says, revenues

Losses deepen at BioMarin

Article | 26 October 2001

BioMarin Pharmaceutical of the USA says that revenues for the thirdquarter of 2001 rose 32.1% to $3.7 million, while its net loss was $11.0 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in